Uzdan Uz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Uzdan Uz has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Görkem Eskiizmir
Manisa Celal Bayar University Faculty of Medicine, Department of Otorhinolaryngology, Manisa, Türkiye
4 shared publications - Onur Celik
Manisa Celal Bayar University, Faculty of Medicine, Department of Otorhinolaryngology, Manisa, Turkey
4 shared publications Görkem Eskiizmir
Department of Otolaryngology-Head & Neck Surgery, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey
3 shared publicationsKıvanç Günhan
Department of Otolaryngology-Head & Neck Surgery, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey
3 shared publicationsOnur Celik
Manisa Celal Bayar Univ, Dept Otorhinolaryngol, Sch Med, Manisa, Turkey
3 shared publications- Arzu Oran
Department of Biochemistry, Faculty of Medicine, Celal Bayar University, Manisa 45030, Türkiye
2 shared publications
Latest Publications
- 28 September 2026
- Published by SAGE Publications in Facial Plastic Surgery & Aesthetic Medicine
Effect of Intraoperative Ice Pack Application on Postoperative Pain, Edema, and Ecchymosis in Rhinoplasty: A Randomized Controlled Trial
Background: Pain, periorbital edema, and ecchymosis are common after rhinoplasty. Intraoperative ice pack application may reduce these sequelae. Objective: To compare 5- and 10-min intraoperative ice pack application with no intraoperative cooling after rhinoplasty. Methods: Thirty-three patients undergoing primary reduction rhinoplasty were randomized to 5-min ice pack application (Group A, n = 11), 10-min ice pack application (Group B, n = 11), or no intraoperative ice pack application (Group C, n = 11). Periorbital edema (0–4), ecchymosis (0–5), and pain (0–10 VAS) were assessed on postoperative days 1, 3, and 7. Results: Pain scores were lower in both ice pack application groups than in the control group on postoperative days 1 (Group A: 4.46 ± 0.72; Group B: 3.96 ± 0.85; Group C: 5.46 ± 0.93; p = 0.003) and 3 (Group A: 3.82 ± 0.56; Group B: 3.41 ± 0.86; Group C: 5.09 ± 0.63; p < 0.001). Edema did not differ among groups on days 1 or 3 but was lower in Groups A and B on day 7 (Group A: 0.09 ± 0.25; Group B: 0.09 ± 0.29; Group C: 0.36 ± 0.47; p = 0.019). Ecchymosis did not differ among groups at any time point. Conclusions: Intraoperative ice pack application was associated with lower pain scores after rhinoplasty. No significant reduction in ecchymosis was observed, and the effect on edema was limited.
- 28 September 2026
- Published by SAGE Publications in Facial Plastic Surgery & Aesthetic Medicine
Effect of Intraoperative Ice Pack Application on Postoperative Pain, Edema, and Ecchymosis in Rhinoplasty: A Randomized Controlled Trial
Background: Pain, periorbital edema, and ecchymosis are common after rhinoplasty. Intraoperative ice pack application may reduce these sequelae. Objective: To compare 5- and 10-min intraoperative ice pack application with no intraoperative cooling after rhinoplasty. Methods: Thirty-three patients undergoing primary reduction rhinoplasty were randomized to 5-min ice pack application (Group A, n = 11), 10-min ice pack application (Group B, n = 11), or no intraoperative ice pack application (Group C, n = 11). Periorbital edema (0–4), ecchymosis (0–5), and pain (0–10 VAS) were assessed on postoperative days 1, 3, and 7. Results: Pain scores were lower in both ice pack application groups than in the control group on postoperative days 1 (Group A: 4.46 ± 0.72; Group B: 3.96 ± 0.85; Group C: 5.46 ± 0.93; p = 0.003) and 3 (Group A: 3.82 ± 0.56; Group B: 3.41 ± 0.86; Group C: 5.09 ± 0.63; p < 0.001). Edema did not differ among groups on days 1 or 3 but was lower in Groups A and B on day 7 (Group A: 0.09 ± 0.25; Group B: 0.09 ± 0.29; Group C: 0.36 ± 0.47; p = 0.019). Ecchymosis did not differ among groups at any time point. Conclusions: Intraoperative ice pack application was associated with lower pain scores after rhinoplasty. No significant reduction in ecchymosis was observed, and the effect on edema was limited.
- Open Access
- 2 April 2026
- Published by Galenos Yayinevi in Turkish Archives of Otorhinolaryngology
- Vol. 64 (2) , 132-136
Decade-Long Progression of Localized Amyloidosis from the Larynx to the Nasal Cavity-A Case Report
Localized amyloidosis of the upper aerodigestive tract is an uncommon and benign condition characterized by extracellular amyloid deposition. While the larynx is the most frequently involved site, progressive, multifocal mucosal involvement remains exceedingly rare. We report the case of a 58-year-old male initially diagnosed with localized laryngeal amyloidosis confirmed via Congo red staining. The initial laryngeal lesions were excised using conservative endoscopic surgery to both confirm the diagnosis and alleviate symptoms. However, no additional treatment was recommended by the rheumatology department since the patient's further evaluations did not indicate a diagnosis of systemic amyloidosis. Over an 11-year follow-up period, sequential progression to the nasopharynx was observed after five years and to the nasal cavity after 11 years. The patient remained free of systemic involvement throughout, confirmed by comprehensive evaluations including serum and urine immunofixation, renal and hepatic panels, and 24-hour urine analysis. Symptomatic relief was achieved with a series of conservative surgical interventions addressing airway and auditory symptoms. The patient remains under active surveillance. This case highlights a rare, progressive pattern of localized amyloidosis involving contiguous mucosal sites in the upper aerodigestive tract. It underscores the importance of long-term follow-up, systematic evaluation to exclude systemic disease, and the efficacy of conservative surgical management. To our knowledge, this is the first reported case of progressive, segmental spread of localized amyloidosis involving the larynx, the nasopharynx, and the nasal cavity over more than a decade.
- 2 April 2026
- Published by Galenos Yayinevi in Turkish Archives of Otorhinolaryngology
- Vol. 64 (2) , 132-136
Open AccessDecade-Long Progression of Localized Amyloidosis from the Larynx to the Nasal Cavity-A Case Report
Localized amyloidosis of the upper aerodigestive tract is an uncommon and benign condition characterized by extracellular amyloid deposition. While the larynx is the most frequently involved site, progressive, multifocal mucosal involvement remains exceedingly rare. We report the case of a 58-year-old male initially diagnosed with localized laryngeal amyloidosis confirmed via Congo red staining. The initial laryngeal lesions were excised using conservative endoscopic surgery to both confirm the diagnosis and alleviate symptoms. However, no additional treatment was recommended by the rheumatology department since the patient's further evaluations did not indicate a diagnosis of systemic amyloidosis. Over an 11-year follow-up period, sequential progression to the nasopharynx was observed after five years and to the nasal cavity after 11 years. The patient remained free of systemic involvement throughout, confirmed by comprehensive evaluations including serum and urine immunofixation, renal and hepatic panels, and 24-hour urine analysis. Symptomatic relief was achieved with a series of conservative surgical interventions addressing airway and auditory symptoms. The patient remains under active surveillance. This case highlights a rare, progressive pattern of localized amyloidosis involving contiguous mucosal sites in the upper aerodigestive tract. It underscores the importance of long-term follow-up, systematic evaluation to exclude systemic disease, and the efficacy of conservative surgical management. To our knowledge, this is the first reported case of progressive, segmental spread of localized amyloidosis involving the larynx, the nasopharynx, and the nasal cavity over more than a decade.
- 21 March 2023
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 34 (3) , e325-e326
Extraordinary Complication of COVID-19 Swab Testing: CSF Rhinorrhea
Coronavirus disease 2019 (COVID-19) is a highly contagious disease that has reached pandemic status. The diagnosis of COVID-19 is made using the polymerase chain reaction test to evaluate a swab taken from the naso/oro-pharyngeal area. Since COVID-19 is still a pandemic, it is thought that the use of this diagnostic test will be on the agenda for a while. A patient with COVID-19 symptoms presented with unilateral cerebrospinal fluid rhinorrhea after a nasopharyngeal swab test. Although nasopharyngeal swabs are taken very frequently, the complication rate is very low. However, life-threatening complications can be observed on rare occasions, and care should be taken.
- 21 March 2023
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 34 (3) , e325-e326
Extraordinary Complication of COVID-19 Swab Testing: CSF Rhinorrhea
Coronavirus disease 2019 (COVID-19) is a highly contagious disease that has reached pandemic status. The diagnosis of COVID-19 is made using the polymerase chain reaction test to evaluate a swab taken from the naso/oro-pharyngeal area. Since COVID-19 is still a pandemic, it is thought that the use of this diagnostic test will be on the agenda for a while. A patient with COVID-19 symptoms presented with unilateral cerebrospinal fluid rhinorrhea after a nasopharyngeal swab test. Although nasopharyngeal swabs are taken very frequently, the complication rate is very low. However, life-threatening complications can be observed on rare occasions, and care should be taken.
- Open Access
- 1 February 2021
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Clinical and Experimental Otorhinolaryngology
- Vol. 14 (1) , 50-60
Association Between Interleukin-6 and Head and Neck Squamous Cell Carcinoma: A Systematic Review
Interleukin-6 (IL-6) is a proinflammatory cytokine which plays an important role in several regulatory mechanisms of cancer. Moreover, experimental and clinical studies have reported that IL-6 targeted therapies might provide significant benefits for cancer treatment. The purpose of this systematic review is to evaluate IL-6 activity in patients with head and neck squamous cell carcinoma (HNSCC). A systematic review of the association between serum, saliva and tumor IL-6 and HNSCC was developed on PubMed/Medline in the publication range from January 1995 to January 2019. Our literature analysis demonstrated that overexpression and elevated serum and/or saliva IL-6 concentrations in patients with HNSCC are related to poor survival and oncological outcomes. Although there is a correlation between IL-6 concentrations and tumorigenicity, it is noteworthy that IL-6 targeted therapies are generally performed in vitro and in experimental studies. Therefore, prospective, randomized clinical trials are required that focus on IL-6 targeted therapies for the treatment of HNSCC.
- 1 February 2021
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Clinical and Experimental Otorhinolaryngology
- Vol. 14 (1) , 50-60
Open AccessAssociation Between Interleukin-6 and Head and Neck Squamous Cell Carcinoma: A Systematic Review
Interleukin-6 (IL-6) is a proinflammatory cytokine which plays an important role in several regulatory mechanisms of cancer. Moreover, experimental and clinical studies have reported that IL-6 targeted therapies might provide significant benefits for cancer treatment. The purpose of this systematic review is to evaluate IL-6 activity in patients with head and neck squamous cell carcinoma (HNSCC). A systematic review of the association between serum, saliva and tumor IL-6 and HNSCC was developed on PubMed/Medline in the publication range from January 1995 to January 2019. Our literature analysis demonstrated that overexpression and elevated serum and/or saliva IL-6 concentrations in patients with HNSCC are related to poor survival and oncological outcomes. Although there is a correlation between IL-6 concentrations and tumorigenicity, it is noteworthy that IL-6 targeted therapies are generally performed in vitro and in experimental studies. Therefore, prospective, randomized clinical trials are required that focus on IL-6 targeted therapies for the treatment of HNSCC.
- Open Access
- 16 December 2019
- Published by AVES YAYINCILIK A.Ş. in The Journal of International Advanced Otology
- Vol. 15 (3) , 420-424
Efficacy of Epley Maneuver on Quality of Life of Elderly Patients with Subjective BPPV
OBJECTIVES: This study aimed to evaluate the efficacy of the repositioning maneuver on quality of life in elderly patients with dizziness and/or vertigo. MATERIALS and METHODS: This controlled, prospective randomized clinical trial was conducted in elderly patients aged 65 years and above with a positive history of benign paroxysmal positional vertigo (BPPV), presence of vertigo, and no observable nystagmus during the Dix-Hallpike test, so-called Subjective BPPV (S-BPPV). Individuals were evaluated by visual analog scale (VAS) and dizziness handicap inventory (DHI). Groups were defined as treatment (treated with Epley maneuver bilaterally) or no treatment control (no treatment modality or canalith repositioning maneuver). Ten days after the first assessment, all patients were reassessed using VAS and DHI. RESULTS: A total of 50 patients were randomized into two groups: 25 to the treatment group, and 25 to the control group. No significant differences were observed for baseline VAS and total DHI scores between the groups (p=0.636, p=0.846, respectively). On the other hand, after the reassessment, VAS and total DHI scores were both significantly reduced in the treatment group (p<0.001, p<0.001, respectively), but no reduction in either score was found in the control group (p=0.216, p=0.731, respectively). CONCLUSION: This study showed that elderly patients with S-BPPV benefit from the Epley maneuver, in particular global and disease-specific quality of life. Cite this article as: Uz U, Uz D, Akdal G, Çelik O. Efficacy of Epley Maneuver on Quality of Life of Elderly Patients with Subjective BPPV. J Int Adv Otol 2019; 15(3): 420-4.
- 16 December 2019
- Published by AVES YAYINCILIK A.Ş. in The Journal of International Advanced Otology
- Vol. 15 (3) , 420-424
Open AccessEfficacy of Epley Maneuver on Quality of Life of Elderly Patients with Subjective BPPV
OBJECTIVES: This study aimed to evaluate the efficacy of the repositioning maneuver on quality of life in elderly patients with dizziness and/or vertigo. MATERIALS and METHODS: This controlled, prospective randomized clinical trial was conducted in elderly patients aged 65 years and above with a positive history of benign paroxysmal positional vertigo (BPPV), presence of vertigo, and no observable nystagmus during the Dix-Hallpike test, so-called Subjective BPPV (S-BPPV). Individuals were evaluated by visual analog scale (VAS) and dizziness handicap inventory (DHI). Groups were defined as treatment (treated with Epley maneuver bilaterally) or no treatment control (no treatment modality or canalith repositioning maneuver). Ten days after the first assessment, all patients were reassessed using VAS and DHI. RESULTS: A total of 50 patients were randomized into two groups: 25 to the treatment group, and 25 to the control group. No significant differences were observed for baseline VAS and total DHI scores between the groups (p=0.636, p=0.846, respectively). On the other hand, after the reassessment, VAS and total DHI scores were both significantly reduced in the treatment group (p<0.001, p<0.001, respectively), but no reduction in either score was found in the control group (p=0.216, p=0.731, respectively). CONCLUSION: This study showed that elderly patients with S-BPPV benefit from the Epley maneuver, in particular global and disease-specific quality of life. Cite this article as: Uz U, Uz D, Akdal G, Çelik O. Efficacy of Epley Maneuver on Quality of Life of Elderly Patients with Subjective BPPV. J Int Adv Otol 2019; 15(3): 420-4.
- 6 November 2019
- Published by Springer Nature
- p. 725-735
Grafting in Nasal Reconstruction
- Open Access
- 4 September 2019
- Published by Medknow in Neurological Sciences and Neurophysiology
- Vol. 36 (3) , 148-151
Does a smartphone application make it easier to evaluate the dizziness handicap inventory?
Neurological Sciences and Neurophysiology
- 4 September 2019
- Published by Medknow in Neurological Sciences and Neurophysiology
- Vol. 36 (3) , 148-151
Open AccessDoes a smartphone application make it easier to evaluate the dizziness handicap inventory?
Neurological Sciences and Neurophysiology
- Open Access
- 3 September 2019
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 12 (3) , 277-281
A Comparison of Thresholds of Auditory Steady-State Response and Auditory Brainstem Response in Healthy Term Babies
OBJECTIVE: The goal of this study was to assess the effectiveness of auditory steady-state response (ASSR), determine the cut-off values for each frequency, and detect the best correlated frequencies when compared with the auditory brainstem response (ABR) thresholds in term babies under the age of 12 months. MATERIALS and METHODS: In total, 88 term babies with a mean age of 2.98 (1–11) months (174 ears) underwent ASSR and ABR tests. The ASSR thresholds for the frequencies of 500, 1000, 2000, and 4000 Hz were compared with the hearing level of the ABR thresholds. In the ABR test, a cut-off value of 30 dB nHL was selected for normal hearing. In addition, the best correlation between the ABR and ASSR thresholds and the estimated cut-off thresholds of ASSR for each of the abovementioned frequencies were obtained. RESULTS: In total, 135 ears had values indicating normal hearing ability and 39 ears had hearing loss according to the ABR thresholds. Although statistically significant correlations were found between the ABR and ASSR thresholds at all frequencies in all groups, these correlations were not strong. On the other hand, a strong correlation was found between the responses of the ABR and ASSR thresholds at 4000 Hz in the hearing-impaired subjects. CONCLUSION: Our findings suggest that ASSR may not be beneficial or reliable as a screening test. Thus, it is likely to be considered as a complementary test rather than an alternative to the ABR test.
- 3 September 2019
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 12 (3) , 277-281
Open AccessA Comparison of Thresholds of Auditory Steady-State Response and Auditory Brainstem Response in Healthy Term Babies
OBJECTIVE: The goal of this study was to assess the effectiveness of auditory steady-state response (ASSR), determine the cut-off values for each frequency, and detect the best correlated frequencies when compared with the auditory brainstem response (ABR) thresholds in term babies under the age of 12 months. MATERIALS and METHODS: In total, 88 term babies with a mean age of 2.98 (1–11) months (174 ears) underwent ASSR and ABR tests. The ASSR thresholds for the frequencies of 500, 1000, 2000, and 4000 Hz were compared with the hearing level of the ABR thresholds. In the ABR test, a cut-off value of 30 dB nHL was selected for normal hearing. In addition, the best correlation between the ABR and ASSR thresholds and the estimated cut-off thresholds of ASSR for each of the abovementioned frequencies were obtained. RESULTS: In total, 135 ears had values indicating normal hearing ability and 39 ears had hearing loss according to the ABR thresholds. Although statistically significant correlations were found between the ABR and ASSR thresholds at all frequencies in all groups, these correlations were not strong. On the other hand, a strong correlation was found between the responses of the ABR and ASSR thresholds at 4000 Hz in the hearing-impaired subjects. CONCLUSION: Our findings suggest that ASSR may not be beneficial or reliable as a screening test. Thus, it is likely to be considered as a complementary test rather than an alternative to the ABR test.
- 1 September 2019
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology (Versão em Português)
- Vol. 85 (5) , 578-587
The evaluation of pretreatment neutrophil–lymphocyte ratio and derived neutrophil–lymphocyte ratio in patients with laryngeal neoplasms
- 1 September 2019
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology (Versão em Português)
- Vol. 85 (5) , 578-587
The evaluation of pretreatment neutrophil–lymphocyte ratio and derived neutrophil–lymphocyte ratio in patients with laryngeal neoplasms